Hendley & Co Inc decreased its stake in Bectondickinson & Company (BDX) by 29.69% based on its latest 2018Q3 regulatory filing with the SEC. Hendley & Co Inc sold 2,252 shares as the company’s stock declined 7.13% with the market. The institutional investor held 5,333 shares of the health care company at the end of 2018Q3, valued at $1.39M, down from 7,585 at the end of the previous reported quarter. Hendley & Co Inc who had been investing in Bectondickinson & Company for a number of months, seems to be less bullish one the $66.67 billion market cap company. The stock decreased 0.82% or $2.04 during the last trading session, reaching $247.42. About 1.00 million shares traded. Becton, Dickinson and Company (NYSE:BDX) has risen 8.55% since February 4, 2018 and is uptrending. It has outperformed by 8.55% the S&P500. Some Historical BDX News: 22/03/2018 – BD AWARE OF CONCERNS ABOUT INACCURATE LEAD TEST; 19/03/2018 – BECTON DICKINSON AND CO – BD INTENDS TO USE PROCEEDS FROM DEAL IN LINE WITH ITS “BROADER CAPITAL ALLOCATION STRATEGY”; 03/05/2018 – Becton Dickinson 2Q Loss/Shr 19c; 19/03/2018 – BECTON DICKINSON AND CO – EXPECTS TO RECORD A GAIN ON TRANSACTION AT TIME OF CLOSING; 26/03/2018 – FDA: Becton Dickinson & Company- BD Vacutainer® Barricor” Lithium Heparin Plasma Blood Collection Tubes for Invitro Diagnostic; 19/03/2018 – BECTON DICKINSON AND CO – DIVESTITURE WILL NOT HAVE A MATERIAL IMPACT TO BD REVENUE OR ADJUSTED EARNINGS FOR FISCAL 2018; 26/04/2018 – FDA: Becton Dickinson & Company- BD Vacutainer® Ultra TouchTM Push Button Blood Collection Set 0.6 x 19 mm x 305 mm 23G x ® x; 19/03/2018 – BDX TO DIVEST REMAINING INVESTMENT IN VYAIRE MEDICAL; 10/04/2018 – Becton Dickinson Closes Above 50-Day Moving Average: Technicals; 27/04/2018 – BD Names Three Executives to Segment Leadership Roles

M Holdings Securities Inc decreased its stake in Johnson & Johnson Com (JNJ) by 16.04% based on its latest 2018Q3 regulatory filing with the SEC. M Holdings Securities Inc sold 3,945 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 20,654 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $2.85 million, down from 24,599 at the end of the previous reported quarter. M Holdings Securities Inc who had been investing in Johnson & Johnson Com for a number of months, seems to be less bullish one the $359.92B market cap company. The stock increased 0.84% or $1.12 during the last trading session, reaching $134.2. About 9.58 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since February 4, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 14/03/2018 – $JNJ highly-anticipated esketamine Ph3 data will be presented at #APAAM18 May 5-9 -; 17/04/2018 – J&J JNJ.N SEES FY 2018 SALES $81 BLN TO $81.8 BLN; 26/04/2018 – J&J REPORTS DIV BOOST OF 7.1% TO 90C/SHR, EST. 88C; 21/03/2018 – J.J. Redick Might Be the N.B.A.’s Most Meticulous Player; 16/03/2018 – J&J nears diabetes device exit with $2.1 bln LifeScan sale; 20/03/2018 – Johnson and Johnson CFO Dominic Caruso to retire in September, to be replaced by Joseph Wolk; 05/03/2018 The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff; 02/04/2018 – J J EXPORTERS LTD JJEX.BO – APPROVAL OF RESIGNATION LETTER FROM S N JHUNJHUNWALA, EXECUTIVE CHAIRMAN; 21/05/2018 – J&J: EMBOTRAP II STENT RETRIEVER FOR ISCHEMIC STROKE; 06/03/2018 – BOEHRINGER INGELHEIM, LILLY EXPAND PROGRAM FOR JARDIANCE

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $136.12’s average target is 1.43% above currents $134.2 stock price. Johnson & Johnson had 111 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Monday, July 10 by BMO Capital Markets. The company was maintained on Wednesday, August 2 by BTIG Research. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Monday, October 5 by Piper Jaffray. The company was maintained on Wednesday, October 14 by S&P Research. As per Friday, June 16, the company rating was maintained by Jefferies. The firm has “Sell” rating given on Wednesday, September 20 by Goldman Sachs. The rating was maintained by Piper Jaffray on Monday, October 2 with “Hold”. The firm has “Hold” rating by Jefferies given on Tuesday, March 15. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, October 17. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Thursday, May 17 by Leerink Swann.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Streetinsider.com which released: “Johnson & Johnson (JNJ) Said to Mull Buying Robotic Surgery Firm Auris – Bloomberg – StreetInsider.com” on January 23, 2019, also Investorplace.com with their article: “5 Top Stock Trades for Wednesday: JNJ, CMG, MO, EBAY – Investorplace.com” published on January 22, 2019, Seekingalpha.com published: “Latest trial over J&J’s talc-based products – Seeking Alpha” on January 08, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Better Buy: Johnson & Johnson vs. AbbVie – The Motley Fool” published on February 02, 2019 as well as Seekingalpha.com‘s news article titled: “EUSA Pharma acquires global rights to SYLVANT – Seeking Alpha” with publication date: January 09, 2019.

M Holdings Securities Inc, which manages about $733.83M and $381.72 million US Long portfolio, upped its stake in Ishares Tr Russell 2000 Etf (IWM) by 19,478 shares to 32,028 shares, valued at $5.40 million in 2018Q3, according to the filing. It also increased its holding in Amazon Com Inc (NASDAQ:AMZN) by 286 shares in the quarter, for a total of 2,449 shares, and has risen its stake in Ishares Tr Global Timber & Forestry Etf (WOOD).

Since August 27, 2018, it had 3 insider buys, and 8 selling transactions for $79.44 million activity. On Monday, December 3 the insider Fasolo Peter sold $24.41M. Gorsky Alex sold $38.60 million worth of stock or 264,465 shares. MULCAHY ANNE M had bought 748 shares worth $100,050. 30,943 shares valued at $4.41 million were sold by Sneed Michael E on Friday, November 23. On Friday, December 14 the insider PRINCE CHARLES bought $268,731. PEREZ WILLIAM D had bought 1,000 shares worth $133,910 on Friday, December 14.

Investors sentiment increased to 1.05 in 2018 Q3. Its up 0.08, from 0.97 in 2018Q2. It is positive, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Gamco Invsts Inc Et Al, a New York-based fund reported 181,988 shares. Everence Cap Management owns 56,502 shares. 31,268 are held by Keystone Fincl Planning. Glenview Bankshares Dept accumulated 71,209 shares. Hills Bank & Trust And Tru invested in 40,910 shares or 1.52% of the stock. Moreover, Washington Trust Bankshares has 0.51% invested in Johnson & Johnson (NYSE:JNJ) for 24,775 shares. New York-based Epoch Invest Partners has invested 0.57% in Johnson & Johnson (NYSE:JNJ). Northstar Asset Management Ltd Limited Liability Company has 2.08% invested in Johnson & Johnson (NYSE:JNJ). Arga Inv Mngmt Ltd Partnership holds 0.54% or 27,725 shares. Blue Financial Capital Inc reported 1.39% of its portfolio in Johnson & Johnson (NYSE:JNJ). Principal Fincl Gp holds 5.58 million shares or 0.68% of its portfolio. Riverhead Capital Mngmt owns 0.66% invested in Johnson & Johnson (NYSE:JNJ) for 132,364 shares. Rodgers Brothers Incorporated, Pennsylvania-based fund reported 69,428 shares. Summit Asset Management Limited Liability holds 13,828 shares. The Michigan-based Chem National Bank & Trust has invested 1.76% in Johnson & Johnson (NYSE:JNJ).

Since November 7, 2018, it had 0 insider purchases, and 7 selling transactions for $18.75 million activity. 5,887 shares were sold by Borzi James W, worth $1.49M on Friday, November 30. 13,498 shares were sold by FORLENZA VINCENT A, worth $3.18M. Another trade for 4,530 shares valued at $1.07M was made by Mas Ribo Alberto on Wednesday, November 14. The insider Polen Thomas E Jr sold 5,243 shares worth $1.28M. 2,080 shares valued at $511,328 were sold by Bodner Charles R on Friday, November 16. 42,000 shares were sold by RING TIMOTHY M, worth $9.96M.

Hendley & Co Inc, which manages about $216.47 million and $203.38 million US Long portfolio, upped its stake in Texas Instruments Inc (NASDAQ:TXN) by 4,018 shares to 60,805 shares, valued at $6.52M in 2018Q3, according to the filing.

More important recent Becton, Dickinson and Company (NYSE:BDX) news were published by: Zacks.com which released: “Becton Dickinson (BDX) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release – Zacks.com” on January 29, 2019, also Seekingalpha.com published article titled: “Short list of expected dividend hikes next week – Seeking Alpha”, Seekingalpha.com published: “Becton, Dickinson sees FQ1 revenues as high as $4.2B – Seeking Alpha” on January 17, 2019. More interesting news about Becton, Dickinson and Company (NYSE:BDX) was released by: Streetinsider.com and their article: “Becton Dickinson (BDX) announces FDA 510(k) clearance of its second generation BD Nano pen needle – StreetInsider.com” with publication date: January 24, 2019.

Among 21 analysts covering Becton Dickinson (NYSE:BDX), 14 have Buy rating, 0 Sell and 7 Hold. Therefore 67% are positive. Becton Dickinson had 64 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Neutral” rating given on Thursday, February 4 by Citigroup. The company was maintained on Tuesday, July 18 by Piper Jaffray. The rating was maintained by Jefferies with “Buy” on Tuesday, July 18. The stock of Becton, Dickinson and Company (NYSE:BDX) earned “Hold” rating by RBC Capital Markets on Thursday, August 3. The stock has “Buy” rating by Jefferies on Tuesday, September 26. As per Wednesday, September 27, the company rating was maintained by Cowen & Co. The firm has “Equal-Weight” rating given on Thursday, October 4 by Morgan Stanley. The rating was upgraded by Citigroup to “Hold” on Friday, January 5. The company was downgraded on Wednesday, January 6 by Evercore. The firm earned “Equal-Weight” rating on Wednesday, February 7 by Morgan Stanley.

Analysts await Becton, Dickinson and Company (NYSE:BDX) to report earnings on February, 5. They expect $2.62 earnings per share, up 5.65% or $0.14 from last year’s $2.48 per share. BDX’s profit will be $705.97 million for 23.61 P/E if the $2.62 EPS becomes a reality. After $2.93 actual earnings per share reported by Becton, Dickinson and Company for the previous quarter, Wall Street now forecasts -10.58% negative EPS growth.